Unknown PHASE2 INTERVENTIONAL 2-arm NCT01946945

Comparison of Standard ART Practice vs. Trophectoderm Biopsy and Whole Chromosome Analysis

Comparison of Standard ART Practice vs. Trophectoderm Biopsy, Whole Chromosome Analysis by Next Generation Sequencing, and Replacement of a Single Euploid Embryo

Sponsor: Main Line Fertility Center

Conditions Infertility Recurrent Pregnancy Loss

Interventions Next Generation Sequencing after Blastocyst biopsy

Updated 5 times since 2017 Last updated: Sep 8, 2014 Started: Sep 30, 2013 Primary completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01946945, this PHASE2 trial focuses on Infertility and Recurrent Pregnancy Loss and remains ongoing. Sponsored by Main Line Fertility Center, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Main Line Fertility Center
Reprogenetics

Data source: Reprogenetics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Livingston, United States